Pancreatic Cancer Went Undetectable in 1 of 12 Patients on a New Pill
A 61-patient trial of the oral drug daraxonrasib stopped tumour growth in nearly everyone and erased detectable cancer in one in 12, a result the report calls the biggest advance in decades.













